Dr @MoetiTshidi discusses South Africa's decision to temporarily pause planned roll out of the Oxford-AstraZeneca #COVID19 vaccine.

This follows a new study showing it has limited efficacy against mild/moderate cases caused by the #SouthAfrica variant. [_link]

— WHO African Region (@WHOAFRO) February 9, 2021

South Africa looking at ways to use AstraZeneca vaccine, advisers say

... their use would be suspended until more evidence was available on whether the vaccine protects against severe COVID-19 from the 501Y.V2 variant, which is more contagious and currently accounts for more than 90% of the country's cases.